Xemperia SA
PrivateLast Round
Seed
Nov 1, 2026
Total Funding Raised
$184,000
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Xemperia SA operates in Healthcare & Life Sciences and is based in Marly. Its latest recorded funding round was a Grant round in January 2025.
Xemperia SA is a biotechnology company that develops blood-based diagnostic tests for the early detection and monitoring of breast cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Xemperia SA Comparables
Compare Xemperia SA with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Exai Bio | 80% | |
| Nine Diagnostics | 78% | |
| Mercy BioAnalytics | 78% |
For institutional investors. Book with your work email.
Xemperia SA Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Nov 1, 2026 | ||||
| Grant | Jan 23, 2025 | ||||
| Grant | Nov 6, 2024 | ||||
| Debt | Jun 27, 2024 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Xemperia SA Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Foundation for Technological Innovation | Debt |
| Venture Kick | Grant |
| Ypsomed Innovation Fund Foundation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 1, 2026
$3.64M raised in Seed round.
- Jul 25, 2026
Monthly visitors increased 41% MoM.
For institutional investors. Book with your work email.
Xemperia SA Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Xemperia SA's valuation, stock price, and market status.
Is Xemperia SA a public or private company?
Xemperia SA is a private company.
What is the current stock price of Xemperia SA?
Xemperia SA is a private company, so its shares have no public market price. Caplight tracks Xemperia SA's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Xemperia SA worth (valuation)?
Valuation information for Xemperia SA is not publicly available.
Can I buy Xemperia SA stock?
Xemperia SA shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Xemperia SA's last funding round?
Xemperia SA's most recent funding round was Seed on November 1, 2026.
Who are the main investors in Xemperia SA?
Key investors in Xemperia SA include Foundation for Technological Innovation, Venture Kick, Ypsomed Innovation Fund Foundation.
Will Xemperia SA IPO soon?
No public IPO plans have been announced for Xemperia SA.
How can I track Xemperia SA secondary market activity?
Caplight tracks bids, offers, and trades in Xemperia SA's shares on secondary markets.